fda banning compounded semaglutide issues warning about some versions of for diabetes, weight loss Semaglutide Shortage Ends: Compounded Versions

adults are overweight or obese, only four percent of these people are prescribed GLP-1 weight-loss medicines due to concerns about safety or effectiveness, lack of healthcare provider training in weight management, excessive costs due to insurance companies refusing coverage and a toxic stigma that portrays obesity as a lack of willpower

As with any medication, microdosing GLP-1 drugs should be undertaken under the guidance of a healthcare provider

Abrahamsson, J

Kooijman, S

For me, its becoming an indispensable part of prescribing GLP-1s responsibly as one piece of a broader lifestyle program, not a standalone fix. The free Noom GLP-1 Companion is available today for anyone who downloads the Noom app